March 26, 2018 / 8:30 PM / a month ago

BRIEF-Aslan Pharmaceuticals Files For U.S. IPO

March 26 (Reuters) - Aslan Pharmaceuticals Ltd :

* ASLAN PHARMACEUTICALS LIMITED FILES FOR U.S. IPO OF UP TO $86.3 MILLION – SEC FILING

* ASLAN PHARMACEUTICALS LIMITED SAYS IT INTENDS TO APPLY TO HAVE ITS ADS LISTED ON NASDAQ GLOBAL MARKET UNDER THE SYMBOL “ASLN”

* ASLAN PHARMACEUTICALS LIMITED SAYS LEERINK PARTNERS, PIPER JAFFRAY ARE AMONG UNDERWRITERS TO IPO

* ASLAN PHARMACEUTICALS LIMITED SAYS BTIG, H.C. WAINWRIGHT & CO, CLSA ARE AMONG UNDERWRITERS TO IPO

* ASLAN PHARMACEUTICALS LIMITED SAYS PROPOSED IPO PRICE IS AN ESTIMATE SOLELY FOR CALCULATING SEC REGISTRATION FEE Source text : (bit.ly/2ISrDXD)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below